Chair of National Allergy Strategy Group - unpaid Chair of Allergy UK Health Advisory Board- unpaid Member of Anaphylaxis Campaign scientific advisory board - unpaid Note that Allergy UK and Anaphylaxis Campaign receive commercial sponsorship. Chair of Joint DHSC/NASG Expert Advisory Committee on Allergy- unpaid NICE non-specialist guideline chair- unpaid
Member of independent drug monitoring committee for commercial clinical trial (ALK-Abello)
Appearances on ITV 'This Morning' & BBC Morning Live - paid Talks on behalf of Allergy Team to schools/school caterers/food retail Talks on behalf of Coaching UK
50% ownership of Allergy London ltd (private practice) 33% ownership of Food Allergy Immunotherapy Ltd (private practice partnership) 33% ownership of Food Allergy Immunotherapy Education Ltd (private practice partnership) 2.5% ownership of HCA Waterfront (private healthcare facility) 30% ownership of Smart Allergy Solutions
£1000- £2000
Speaker at 11th UHS Pediatric & Neonatology International conference, Dubai – economy class ticket and accommodation, Jan 2024 Attendance at EAACI Taskforce meeting Athens, December 2024
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Consultancy/medical writing for Evoke mind+matter
Member of independent drug monitoring committee for commercial clinical trial (ALK-Abello) Incoming co-chair of EUFOREA (European Forum for Research & Education in Allergy & Airway Disease) Paediatric Expert Panel
Chair of National Allergy Strategy Group - unpaid Chair of Allergy UK Health Advisory Board- unpaid Member of Anaphylaxis Campaign scientific advisory board - unpaid Note that Allergy UK and Anaphylaxis Campaign receive commercial sponsorship. Chair of Joint DHSC/NASG Expert Advisory Committee on Allergy- unpaid Expert member of NICE Health Technology Appraisal and non-specialist guideline chair- unpaid Appearances on ITV 'This Morning' Talks on behalf of Allergy Team to schools/school caterers/food retail
50% ownership of Allergy London ltd (private practice) 33% ownership of Food Allergy Immunotherapy Ltd (private practice partnership) 33% ownership of Food Allergy Immunotherapy Education Ltd (private practice partnership) 2.5% ownership of HCA Waterfront (private healthcare facility) 30% ownership of Smart Allergy Solutions
£5000 - £10000
Speaker at 11th UHS pediatric & Neonatology International conference, Dubai – economy class ticket and accommodation, Jan 2024 Speaker at BSACI Annual Conference, Harrogate, 2023 – travel and accommodation Speaker at ACAAI conference, Anaheim, 2023 – travel and accommodation
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Trustee & Immediate past president of British Society for Allergy & Clinical Immunology - unpaid Chair of National Allergy Strategy Group - unpaid Chair of Allergy UK Health Advisory Board- unpaid Member of Anaphylaxis Campaign scientific advisory board - unpaid Note that BSACI, Allergy UK and Anaphylaxis Campaign receive commercial sponsorship. Non-specialist guideline chair, NICE - unpaid Unpaid advisory roles for start-ups Allergy Team.
Member of Independent Safety Committee for 2 ALK-Abello commercial studies
Talks on behalf of Aimmune, Tooled Up, EUFOREA & Allergy Team. Appearances on ITV 'This Morning'
HCA Elstree 2.5% ownership stake in private healthcare facility Allergy London Director (50% ownership), Private practice Food Allergy Immunotherapy ltd Director, 33% ownership. Group private practice Food Allergy Immunotherapy Education ltd Director, 3% ownership Smart Allergy Solutions Director and 30% equity
£2000 - £5000
Travel, accommodation & registration as a speaker at WAO/BSACI Annua Meeting, Edinburgh 2022 & MEARC Dubai, 2023
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Trustee & Immediate past president of British Society for Allergy & Clinical Immunology - unpaid Chair of Allergy UK Health Advisory Board- unpaid Member of Anaphylaxis Campaign scientific advisory board - unpaid Note that BSACI, Allergy UK and Anaphylaxis Campaign receive commercial sponsorship. Member of MHRA expert working groups (Adrenaline Autoinjectors and COVID vaccine reactions) Expert member of NICE Health Technology Appraisal and non-specialist guideline chair Chair Elect of National Allergy Strategy Group - unpaid Unpaid advisory roles for start-ups Allergy Team, Allergi, Nuki. Consultancy for Aimmune (on behalf of NHS Trust consulting arm) - no personal fee
Member of independent drug monitoring committee for commercial clinical trial (ALK-Abello)
Appearances on ITV 'This Morning'
50% ownership of Allergy London ltd (private practice) 33% ownership of Food Allergy Immunotherapy Ltd (private practice partnership) 2.5% ownership of HCA Waterfront (private healthcare facility)
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
MHRA Expert working group on AAIs & vaccine allergy Woodgate and Clark Solicitors Expert witness Food Standards Agency Advisory Board (unpaid) Allergy UK Chair of Health Advisory Panel (unpaid) Anaphylaxis Campaign Member of Advisory panel (unpaid) BSACI including representation on NASG (President (2018 - )) (unpaid) Allergi Unpaid advisory board – no equity stake/financial interest Nuki Unpaid advisory board – no equity stake/financial interest Allergy Team Unpaid advisory board – no equity stake/financial interest I have been doing advisory work for Aimmune through GST consulting (NHS Trust consulting arm) with no personal fee
Appearances on ITV 'This Morning'
HCA Elstree 2.5% ownership stake in private healthcare facility Allergy London Director, Private practice
£100- £1000
Travel (economy) and accommodation in Dubai to speak at Middle East Paediatric Allergy & Respiratory Conference. No personal fee.
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
HM Coroner's court - Expert witness work in relation to inquest, November 2019. I have consulted for companies (DBV technologies, Stallergenes) on behalf of my NHS trust, as part of my regular NHS employment. No personal fees received.
Previous studies with ALK-Abello or Danone, ended in 2019.
President of BSACI, unpaid. BSACI receives industry sponsorship, please see bsaci.org. Chair of Allergy UK health advisory board, unpaid. Allergy UK receives industry sponsorship, please see allergyuk.org. Member of National Allergy Strategy Group. NASG receives industry sponsorship, please see nasguk.org. Advisor to charities including Anaphylaxis Campaign, unpaid. Governor, North London Collegiate School, unpaid.
HCA Waterfront, Elstree. Investor (2.5% equity). 50% owner of Allergy London ltd (Private practice)
Travel, registration & attendance at EAACI conference, Lisbon as speaker. Travel, registration & attendance at BSACI conference, Harrogate as session chair. Travel and speaker fee for lecture at National Immunisation Conference, Manchester.
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
MHRA Expert Working Group on Adrenaline Auto-injectors
ITV 'This Morning'
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| DBV laboratories | Consultancy relating to peanut epicutaneous desensitization & lecture Sept 2018. | £1000- £2000 |
| Aimmune | Consultancy relating to peanut oral desensitisation. | £1000- £2000 |
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| Metropolitan Police | Expert witness for coroner’s inquest | £1000- £2000 |
| University College Cork | External Examiner for Undergraduate Paediatrics | £100- £1000 |
| KCL Allergy Academy | Director. NHS salary recharge for 1 PA. Academy supported by multiple industry sponsors - see allergyacademy.org | £5000 - £10000 |
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| HCA Waterfront Elstree | Investor (2.5% equity) | under £100 |
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| ALK-Abello | MT-11 study - Institutional Funding for Commercial Research (including part contribution to NHS salary recharge for 1 research PA) | £5000 - £10000 |
| Danone | PRESTO study - Institutional Funding for Commercial Research (including part contribution to NHS salary recharge for 1 research PA) | £5000 - £10000 |
This section relates to activity since the last declaration in July 2018
Stallergenes Greer - Consultancy relating to sublingual immunotherapy done on behalf of NHS trust. No personal payment.
President of BSACI, unpaid. BSACI receives industry sponsorship, please see bsaci.org. Trustee of Allergy UK (& Chair of health advisory board), unpaid. Allergy UK receives industry sponsorship, please see allergyuk.org. Advisor to charities including Anaphylaxis Campaign, Living with Reflux, FABED (Families living with Eosinophilic Disorders), unpaid. Governor, North London Collegiate School, unpaid. Lecture given at Sharjah University Hospital Annual Paediatric Conference, Dubai, February 2019. No payment but flight and accommodation paid for by event organiser.
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| Danone | Advisory Boards, Lecturing & medical writing | £10000 - £50 000 |
| Stallergenes Greer | Lecturing | £2000 - £5000 |
| DBV technologies | Advisory Boards & Lecturing | £1000- £2000 |
| Nestle Nutrition | Medical writing | £1000- £2000 |
| Mead Johnson | Advisory Boards, Lecturing | £5000 - £10000 |
| Aimmune | Consultancy on market access | £5000 - £10000 |
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| F2F Events | Clinical Director of CPD Event for Allergy & Free From Show | £2000 - £5000 |
| KCL Allergy Academy | Director. NHS salary recharge for 1 PA (approx. £10,000 annually). Academy supported by multiple industry sponsors. | £5000 - £10000 |
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| HCA Elstree | Investor (2.5% equity) | under £100 |
| Company | Reason for receipt of fees | Total amount received |
|---|---|---|
| Danone | Institutional Funding for Commercial Research including part contribution to NHS salary recharge for 1 PA (approx. £10,000 annually) | £2000 - £5000 |
| ALK-Abello | Institutional Funding for Commercial Research including part contribution to NHS salary recharge for 1 PA (approx. £10,000 annually) | £2000 - £5000 |
BSACI - President (from Oct 2018), No payment Allergy UK Trustee & Chair of Health Advisory Board, No payment